Q4 EPS Estimates for Evolent Health Reduced by William Blair

Evolent Health, Inc. (NYSE:EVHFree Report) – Investment analysts at William Blair reduced their Q4 2024 earnings per share estimates for shares of Evolent Health in a research note issued on Thursday, January 30th. William Blair analyst R. Daniels now anticipates that the technology company will post earnings per share of ($0.06) for the quarter, down from their previous estimate of ($0.05). The consensus estimate for Evolent Health’s current full-year earnings is $0.24 per share.

Other analysts have also recently issued reports about the company. BTIG Research cut their price objective on Evolent Health from $36.00 to $29.00 and set a “buy” rating on the stock in a research report on Tuesday, December 3rd. JPMorgan Chase & Co. dropped their price target on Evolent Health from $15.00 to $13.00 and set an “overweight” rating on the stock in a research report on Tuesday, January 28th. Citigroup decreased their price objective on Evolent Health from $21.00 to $18.00 and set a “buy” rating for the company in a report on Friday, January 10th. KeyCorp started coverage on shares of Evolent Health in a research report on Friday, October 11th. They issued an “overweight” rating and a $35.00 target price on the stock. Finally, Royal Bank of Canada lowered their price target on shares of Evolent Health from $20.00 to $17.00 and set an “outperform” rating for the company in a research report on Tuesday, January 14th. One investment analyst has rated the stock with a hold rating, eleven have given a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Buy” and an average price target of $18.38.

Check Out Our Latest Stock Analysis on Evolent Health

Evolent Health Price Performance

Shares of NYSE EVH opened at $10.27 on Monday. Evolent Health has a 1 year low of $9.74 and a 1 year high of $35.00. The stock has a market capitalization of $1.20 billion, a P/E ratio of -11.28 and a beta of 1.45. The company’s 50-day moving average is $11.22 and its 200 day moving average is $19.91. The company has a debt-to-equity ratio of 0.58, a current ratio of 1.04 and a quick ratio of 1.04.

Evolent Health (NYSE:EVHGet Free Report) last announced its earnings results on Thursday, November 7th. The technology company reported ($0.08) EPS for the quarter, missing analysts’ consensus estimates of $0.30 by ($0.38). The business had revenue of $621.40 million for the quarter, compared to the consensus estimate of $625.58 million. Evolent Health had a negative net margin of 2.93% and a positive return on equity of 6.30%. During the same quarter in the prior year, the company earned $0.19 EPS.

Hedge Funds Weigh In On Evolent Health

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Covestor Ltd lifted its holdings in shares of Evolent Health by 138.1% during the third quarter. Covestor Ltd now owns 1,424 shares of the technology company’s stock valued at $40,000 after purchasing an additional 826 shares in the last quarter. GAMMA Investing LLC raised its position in Evolent Health by 5,365.5% in the 3rd quarter. GAMMA Investing LLC now owns 1,585 shares of the technology company’s stock worth $45,000 after buying an additional 1,556 shares during the last quarter. Quarry LP bought a new position in Evolent Health during the 2nd quarter valued at about $32,000. Creative Planning boosted its holdings in shares of Evolent Health by 12.2% during the 2nd quarter. Creative Planning now owns 18,091 shares of the technology company’s stock valued at $346,000 after acquiring an additional 1,973 shares during the last quarter. Finally, R Squared Ltd bought a new stake in shares of Evolent Health in the fourth quarter worth approximately $31,000.

Evolent Health Company Profile

(Get Free Report)

Evolent Health, Inc, through its subsidiary, Evolent Health LLC, offers specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company provides platform for health plan administration and value-based business infrastructure. It offers administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients.

See Also

Receive News & Ratings for Evolent Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evolent Health and related companies with MarketBeat.com's FREE daily email newsletter.